Takeda Pharmaceutical Company Limited (TYO:4502)
Japan flag Japan · Delayed Price · Currency is JPY
5,631.00
+23.00 (0.41%)
Mar 5, 2026, 3:30 PM JST

TYO:4502 Ratios and Metrics

Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
8,858,90046,80043,58751,23745,31657,094
Market Cap Growth
36.47%7.37%-14.93%13.07%-20.63%20.72%
Enterprise Value
13,627,07546,8004,415,1813,880,4233,516,2313,693,785
PE Ratio
79.5866.3246.1521.6723.9116.93
Forward PE
33.87-----
PEG Ratio
1.46-----
PS Ratio
1.980.010.010.010.010.02
PB Ratio
1.16-0.010.010.010.01
P/TBV Ratio
---0.010.010.01
P/FCF Ratio
8.770.050.080.060.050.06
P/OCF Ratio
7.450.040.060.050.040.06
EV/Sales Ratio
3.050.011.040.960.991.16
EV/EBITDA Ratio
10.310.044.143.183.203.38
EV/EBIT Ratio
22.690.1423.497.927.637.25
EV/FCF Ratio
13.480.058.164.643.524.11
Debt / Equity Ratio
0.63-0.670.690.760.90
Debt / EBITDA Ratio
8.00-4.543.603.964.24
Debt / FCF Ratio
--8.965.244.355.15
Net Debt / Equity Ratio
0.54-0.600.600.610.70
Net Debt / EBITDA Ratio
6.74-4.103.143.163.32
Net Debt / FCF Ratio
--8.084.583.474.04
Asset Turnover
0.300.610.290.300.270.25
Inventory Turnover
1.172.611.301.351.381.31
Quick Ratio
0.58-0.480.500.751.02
Current Ratio
1.19-1.060.971.211.53
Return on Equity (ROE)
4.52%2.97%2.12%5.27%4.24%7.60%
Return on Assets (ROA)
4.77%6.27%-3.12%4.16%4.38%3.85%
Return on Invested Capital (ROIC)
5.36%6.98%-3.51%4.79%5.09%4.40%
Return on Capital Employed (ROCE)
4.70%5.40%1.56%4.35%4.16%4.68%
Earnings Yield
1.27%1.51%2.17%4.61%4.18%5.91%
FCF Yield
11.41%1829.87%1241.02%1632.60%2206.42%1575.87%
Dividend Yield
3.49%0.00%0.00%4.11%5.20%4.48%
Payout Ratio
277.04%280.54%199.34%88.14%123.30%75.36%
Buyback Yield / Dilution
-110.81%5.34%52.56%171.09%3.75%
Total Shareholder Return
-110.81%5.34%56.67%176.29%8.23%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.